Literature DB >> 23313266

Hypertension and low HDL cholesterol were associated with reduced kidney function across the age spectrum: a collaborative study.

Michelle C Odden1, Ira B Tager, Ron T Gansevoort, Stephan J L Bakker, Linda F Fried, Anne B Newman, Ronit Katz, Suzanne Satterfield, Tamara B Harris, Mark J Sarnak, David Siscovick, Michael G Shlipak.   

Abstract

PURPOSE: To determine if the associations among established risk factors and reduced kidney function vary by age.
METHODS: We pooled cross-sectional data from 14,788 nondiabetics aged 40 to 100 years in 4 studies: Cardiovascular Health Study, Health, Aging, and Body Composition Study, Multi-Ethnic Study of Atherosclerosis, and Prevention of Renal and Vascular End-Stage Disease cohort.
RESULTS: Hypertension and low high-density lipoprotein (HDL) cholesterol were associated with reduced cystatin C-based estimated glomerular filtration rate (eGFR) across the age spectrum. In adjusted analyses, hypertension was associated with a 2.3 (95% confidence interval [CI], 0.1, 4.4), 5.1 (95% CI, 4.1, 6.1), and 6.9 (95% CI, 3.0, 10.4) mL/min/1.73 m(2) lower eGFR in participants 40 to 59, 60 to 79, and at least 80 years, respectively (P for interaction < .001). The association of low HDL cholesterol with reduced kidney function was also greater in the older age groups: 4.9 (95% CI, 3.5, 6.3), 7.1 (95% CI, 6.0, 8.3), 8.9 (95% CI, 5.4, 11.9) mL/min/1.73 m(2) (P for interaction < .001). Smoking and obesity were associated with reduced kidney function in participants under 80 years. All estimates of the potential population impact of the risk factors were modest.
CONCLUSIONS: Hypertension, obesity, smoking, and low HDL cholesterol are modestly associated with reduced kidney function in nondiabetics. The associations of hypertension and HDL cholesterol with reduced kidney function seem to be stronger in older adults.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23313266      PMCID: PMC3570601          DOI: 10.1016/j.annepidem.2012.12.004

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  33 in total

1.  Serum cystatin C concentration as a marker of renal dysfunction in the elderly.

Authors:  D Fliser; E Ritz
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

2.  IFCC recommendation on reporting results for blood glucose.

Authors:  R W Burnett; P D'Orazio; N Fogh-Andersen; K Kuwa; W R Külpmann; L Larsson; A Lewnstam; A H Maas; G Mager; U Spichiger-Keller
Journal:  Clin Chim Acta       Date:  2001-05       Impact factor: 3.786

3.  Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.

Authors:  Auke H Brantsma; Stephan J L Bakker; Hans L Hillege; Dick de Zeeuw; Paul E de Jong; Ronald T Gansevoort
Journal:  Diabetes Care       Date:  2005-10       Impact factor: 19.112

Review 4.  Update on cystatin C: new insights into the importance of mild kidney dysfunction.

Authors:  Michael G Shlipak; Melanie L Praught; Mark J Sarnak
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-05       Impact factor: 2.894

5.  The relationship between blood pressure and mortality in the oldest old.

Authors:  S Satish; D H Freeman; L Ray; J S Goodwin
Journal:  J Am Geriatr Soc       Date:  2001-04       Impact factor: 5.562

6.  Age-related associations of hypertension and diabetes mellitus with chronic kidney disease.

Authors:  Tareq M Islam; Caroline S Fox; Devin Mann; Paul Muntner
Journal:  BMC Nephrol       Date:  2009-06-30       Impact factor: 2.388

7.  Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System.

Authors:  E J Erlandsen; E Randers; J H Kristensen
Journal:  Scand J Clin Lab Invest       Date:  1999-02       Impact factor: 1.713

8.  Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study.

Authors:  Esther M Briganti; Pauline Branley; Steven J Chadban; Jonathan E Shaw; John J McNeil; Timothy A Welborn; Robert C Atkins
Journal:  Am J Kidney Dis       Date:  2002-10       Impact factor: 8.860

Review 9.  Focal and segmental glomerulosclerosis: analogies to atherosclerosis.

Authors:  J R Diamond; M J Karnovsky
Journal:  Kidney Int       Date:  1988-05       Impact factor: 10.612

Review 10.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.

Authors:  M R Law; J K Morris; N J Wald
Journal:  BMJ       Date:  2009-05-19
View more
  11 in total

1.  Metabolic syndrome and risk of incident peripheral artery disease: the cardiovascular health study.

Authors:  Parveen K Garg; Mary L Biggs; Mercedes Carnethon; Joachim H Ix; Michael H Criqui; Kathryn A Britton; Luc Djoussé; Kim Sutton-Tyrrell; Anne B Newman; Mary Cushman; Kenneth J Mukamal
Journal:  Hypertension       Date:  2013-11-04       Impact factor: 10.190

2.  An Illustration of Inverse Probability Weighting to Estimate Policy-Relevant Causal Effects.

Authors:  Jessie K Edwards; Stephen R Cole; Catherine R Lesko; W Christopher Mathews; Richard D Moore; Michael J Mugavero; Daniel Westreich
Journal:  Am J Epidemiol       Date:  2016-07-28       Impact factor: 4.897

3.  The association between high-density lipoproteins and estimated glomerular filtration rate in patients without severe kidney disease.

Authors:  Domagoj Markovic; Gorana Trgo; Ingrid Prkacin; Damir Fabijanic; Vedran Kovacic
Journal:  Int Urol Nephrol       Date:  2018-03-28       Impact factor: 2.370

Review 4.  Kidneys: key modulators of high-density lipoprotein levels and function.

Authors:  Haichun Yang; Agnes B Fogo; Valentina Kon
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-05       Impact factor: 2.894

5.  APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans.

Authors:  Amy R Bentley; Jasmin Divers; Daniel Shriner; Ayo P Doumatey; Orlando M Gutiérrez; Adebowale A Adeyemo; Barry I Freedman; Charles N Rotimi
Journal:  BMC Genomics       Date:  2015-05-30       Impact factor: 3.969

6.  Association between high-density lipoprotein cholesterol and renal function in elderly hypertension: a cross-sectional study in Chinese population.

Authors:  Ya-Ping Zhang; Ming-Gen Lu; Dayue Darrel Duan; Ying-Long Liu; Meilin Liu; Ying Li; Ze-Min Kuang; Yao Lu; Xing Liu; Xiao-Hui Li; Hong Yuan
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

7.  Epigenetic markers of renal function in african americans.

Authors:  Samantha M Bomotti; Jennifer A Smith; Alicia L Zagel; Jacquelyn Y Taylor; Stephen T Turner; Sharon L R Kardia
Journal:  Nurs Res Pract       Date:  2013-12-12

8.  High-Density Lipoprotein Cholesterol Concentration and Acute Kidney Injury After Cardiac Surgery.

Authors:  Loren E Smith; Derek K Smith; Jeffrey D Blume; MacRae F Linton; Frederic T Billings
Journal:  J Am Heart Assoc       Date:  2017-12-09       Impact factor: 5.501

9.  Association of high-density lipoprotein cholesterol with the estimated glomerular filtration rate in a community-based population.

Authors:  Fan Wang; Jin Zheng; Ping Ye; Leiming Luo; Yongyi Bai; Ruyi Xu; Li Sheng; Tiehui Xiao; Hongmei Wu
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

10.  Correlation between Serum Lipid Levels and Measured Glomerular Filtration Rate in Chinese Patients with Chronic Kidney Disease.

Authors:  Yanni Wang; Xilian Qiu; Linsheng Lv; Caixia Wang; Zengchun Ye; Shaomin Li; Qiong Liu; Tanqi Lou; Xun Liu
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.